Why Does CPAP Therapy Lower Blood Pressure?

CPAP therapy lowers blood pressure primarily by preventing the repeated airway collapses of obstructive sleep apnea, which in turn dials down several mechanisms that drive blood pressure up overnight and throughout the day. The effect is not massive in most patients, often in the range of a few millimeters of mercury, but it operates through multiple overlapping pathways: quieting the body’s stress-hormone response, reducing inflammation, easing the mechanical workload on the heart, and restoring the normal nighttime dip in blood pressure that sleep apnea disrupts. The size of the benefit depends heavily on who you are and how consistently you use the device.

What Sleep Apnea Does to Blood Pressure in the First Place

During an obstructive apnea event, the upper airway collapses and airflow stops. Oxygen levels drop, carbon dioxide builds up, and the brain jolts you into a partial awakening to restore breathing. This cycle can repeat dozens or even hundreds of times per night. Each episode triggers a spike in sympathetic nervous system activity, the fight-or-flight response that constricts blood vessels, speeds up the heart, and raises blood pressure. Over months and years, that nightly barrage of stress activation spills over into daytime physiology, keeping blood pressure elevated even while you are awake and breathing normally.

CPAP works by delivering a steady stream of pressurized air through a mask, splinting the airway open so it does not collapse. By preventing the apneas themselves, CPAP removes the trigger for these cascading cardiovascular effects. But the blood pressure benefit is not simply “airway open, pressure down.” Several distinct biological pathways are involved, and understanding them helps explain why the therapy works well for some people and barely moves the needle for others.

Quieting the Sympathetic Nervous System

The most well-established pathway involves the sympathetic nervous system. In people with untreated sleep apnea, sympathetic nerve traffic is chronically elevated, not just at night but during waking hours too. Researchers have measured this directly by recording nerve signals from the peroneal nerve (a nerve in the lower leg that reflects overall sympathetic drive). After an extended course of CPAP therapy, that daytime sympathetic traffic drops significantly.¹ The key word there is “extended.” A single night of CPAP does not reset the sympathetic nervous system. The calming effect appears only after weeks of consistent use, suggesting the body needs sustained relief from repeated oxygen drops before the nervous system recalibrates.

Related to this is the baroreflex, the body’s built-in feedback loop for keeping blood pressure steady. Baroreceptors in the carotid arteries and aorta sense pressure changes and signal the brain to adjust heart rate and vessel tone accordingly. In sleep apnea, this reflex becomes blunted, meaning the body is worse at correcting blood pressure spikes. CPAP improves baroreflex sensitivity and resets its operating point to a lower blood pressure.² In one study of heart failure patients with sleep apnea, the baroreflex slope roughly doubled on CPAP, and the systolic pressure at the midpoint of the reflex’s range fell from about 139 to 120 mmHg.² Separate work in sleep apnea patients without heart failure confirmed the improvement in baroreflex measures with CPAP treatment.³

Reducing Inflammation and Protecting Blood Vessels

Sleep apnea is an inflammatory condition. The repeated drops in oxygen and subsequent re-oxygenation create oxidative stress, similar in some ways to repeated mini episodes of oxygen starvation. This drives up circulating inflammatory markers, including C-reactive protein (CRP), interleukin-6, and tumor necrosis factor-alpha (TNF-α). All of these contribute to blood vessel damage and stiffness over time, which raises blood pressure.

A meta-analysis of randomized controlled trials found that CPAP therapy produced significant reductions in CRP and TNF-α levels.⁴ The drop in TNF-α was consistent across studies with essentially no statistical disagreement between trial results, which suggests the effect is real and reproducible.

Inflammation damages the endothelium, the thin lining of blood vessels that plays an active role in controlling vessel tone. In sleep apnea, endothelial nitric oxide availability (the molecule that tells blood vessels to relax) is reduced, while oxidative stress is elevated. Treating sleep apnea with CPAP improves endothelial function and reduces inflammation, helping blood vessels dilate more effectively.⁵ This matters because stiff, poorly functioning blood vessels are a direct driver of high blood pressure.

Making Arteries Less Stiff

Arterial stiffness is typically measured using pulse wave velocity, which assesses how fast a pressure wave travels through the arteries. Faster waves mean stiffer arteries and higher cardiovascular risk. A meta-analysis of randomized trials found that CPAP reduced pulse wave velocity in sleep apnea patients, indicating measurably less stiff arteries.⁶ One open-label study found the improvement in arterial stiffness appeared within two months and persisted at four months, even though standard blood pressure readings in that particular study did not change.⁷

That finding is worth pausing on. It suggests CPAP can improve the health of the vascular system in ways that don’t immediately show up on a blood pressure cuff but still reduce long-term cardiovascular risk. The arteries become more compliant and flexible, even if the conventional systolic and diastolic numbers in a given study take longer to shift.

Easing the Mechanical Load on the Heart

There is also a direct mechanical component. During obstructive apneas, the person tries to inhale against a closed airway, generating large swings in pressure inside the chest. These swings increase the pressure difference across the wall of the left ventricle, effectively making the heart work harder to pump blood out. CPAP raises intrathoracic pressure slightly and stabilizes it, which reduces this extra workload. In patients with congestive heart failure, CPAP at a standard clinical pressure significantly decreased the transmural pressure the left ventricle had to pump against, without reducing cardiac output.⁸ In plain terms, the heart had an easier job moving the same amount of blood. Healthy subjects did not show the same change, which makes sense: their hearts were not under the same strain to begin with.

Hormonal Effects on Aldosterone and the Kidneys

Sleep apnea activates the renin-angiotensin-aldosterone system, a hormonal cascade that regulates blood pressure partly by controlling how much salt and water your kidneys retain. Aldosterone, the final hormone in that chain, tells the kidneys to hold onto sodium, which increases blood volume and raises pressure. A systematic review and meta-analysis found that CPAP significantly reduced plasma aldosterone levels, with the strongest effect in patients under 50 and in those who adhered to treatment for at least three months.⁹ Upstream components of the system, such as renin and angiotensin II, did not change significantly in the overall group, suggesting that CPAP’s hormonal effect may be more targeted at the aldosterone end than at the system as a whole.

Downstream of those hormonal changes, there is evidence that kidney function improves. In patients with moderate to severe sleep apnea, one month of CPAP reduced urinary albumin excretion, a marker of kidney stress. The improvement tracked with the severity of nighttime oxygen desaturation, linking the kidney benefit directly to the resolution of overnight oxygen drops.¹⁰

Restoring the Nighttime Blood Pressure Dip

In people without sleep apnea, blood pressure normally drops by about 10 to 20 percent during sleep, a pattern called “dipping.” Sleep apnea disrupts this pattern, turning many patients into “non-dippers” whose blood pressure stays elevated or barely falls overnight. Non-dipping is associated with higher cardiovascular risk independent of average blood pressure levels, and it is linked to a greater chance of developing conditions like diabetes.¹¹

CPAP is particularly effective at restoring this nighttime dip. The HIPARCO trial, which randomized patients with both sleep apnea and resistant hypertension (high blood pressure that does not respond adequately to three or more medications), found that CPAP use over 12 weeks more than doubled the proportion of patients who recovered a normal dipping pattern compared to a control group. In the CPAP group, about 36 percent were dippers at follow-up versus about 22 percent in the control group. The overall 24-hour mean blood pressure decrease was about 3 mmHg greater with CPAP, and the diastolic improvement was similarly around 3 mmHg.¹²

A few millimeters of mercury might not sound dramatic, but in the context of resistant hypertension, where additional medications fail to move the numbers much, that reduction is clinically meaningful. Meta-analyses confirm that the nighttime blood pressure improvement is one of the most consistent effects of CPAP when the device is used for at least four hours a night over 12 or more weeks.¹¹

Why the Blood Pressure Benefit Is Not the Same for Everyone

One of the biggest sources of confusion around CPAP and blood pressure is the wide variation in results across clinical trials. Some studies report drops of 5 to 10 mmHg, while large trials like SAVE found only about 2 mmHg of improvement. The explanation lies partly in who was enrolled. In the SAVE trial, patients already had well-controlled blood pressure on medication at the start, and average CPAP use was only about 3.3 hours per night, which is below the threshold where the strongest benefits appear.¹³ If blood pressure is already controlled, there is less room for CPAP to push it lower.

Sleepiness matters too, and in a counterintuitive way. A trial of hypertensive sleep apnea patients who were not particularly sleepy found that CPAP did not produce significant blood pressure reductions, regardless of how severe their apnea was.¹⁴ Previous studies that reported larger blood pressure drops tended to enroll patients with symptomatic, excessive daytime sleepiness. The reason is not entirely clear, but one theory is that sleepy patients have greater sympathetic activation and more disrupted sleep architecture, giving CPAP more room to work. For patients with uncontrolled hypertension, CPAP has been described as a potentially important addition to blood pressure medications.¹⁵

Adherence is the other major predictor. Across studies, the blood pressure benefit is consistently larger in people who wear their CPAP for more hours and for more months. The aldosterone reduction mentioned earlier, for example, was strongest in patients who stuck with therapy for at least three months.⁹ The sympathetic nerve calming also requires extended use. A single night provides zero benefit on that front.

What Happens When You Stop Using CPAP

A randomized trial that withdrew CPAP from established users paints a vivid picture of what happens when the device goes away. Within just two weeks, sleep apnea returned in full, and morning systolic blood pressure rose by about 9 mmHg more than in the group that continued CPAP. Morning diastolic pressure climbed by roughly 7 mmHg, and resting heart rate increased by about 6 beats per minute. Urinary catecholamines, markers of sympathetic nervous system activation, also increased.¹⁶

Interestingly, markers of systemic inflammation did not spike within that two-week withdrawal period, suggesting that the inflammatory pathway takes longer to reactivate than the sympathetic nervous system pathway. The blood pressure rebound, in other words, is driven first by the nervous system snapping back to its hyperactivated state, with inflammatory changes potentially following over a longer timeline. This finding reinforces that CPAP is a treatment, not a cure. The blood pressure benefit persists only as long as you keep using the device.

Mandibular Advancement Devices as an Alternative

Not everyone tolerates CPAP. For those people, mandibular advancement devices (custom-fitted oral appliances that push the lower jaw forward to keep the airway open) are a common alternative. A head-to-head trial comparing the two found that the mandibular device actually produced a larger reduction in 24-hour mean arterial blood pressure at six months, about 2.5 mmHg, while the CPAP group showed no statistically significant change from baseline.¹⁷ The mandibular device showed the most pronounced benefit during sleep, consistent with the nighttime blood pressure dipping mechanism. This does not mean oral appliances are always better for blood pressure; the result may reflect better nightly adherence with a device that is simpler and more comfortable for many users. The trial met its noninferiority endpoint, meaning the oral device was at least as effective as CPAP for blood pressure.

What CPAP Does Not Fix

For all its documented cardiovascular benefits, CPAP does not improve everything. A study specifically examining cerebral autoregulation, the brain’s ability to maintain steady blood flow despite changes in blood pressure, found that one month of CPAP treatment did not improve this function in sleep apnea patients.¹⁸ Patients with more severe sleep apnea had altered cerebral autoregulation compared to milder cases and controls, but CPAP did not correct it. This is a reminder that CPAP addresses the trigger (the apnea events) quite effectively but cannot necessarily reverse all the structural or functional changes that years of untreated sleep apnea may have caused in the vascular system.

The CPAP withdrawal trial also noted that while blood pressure and sympathetic markers rebounded quickly after stopping therapy, markers of insulin resistance and blood lipids did not deteriorate within the two-week window.¹⁶ This hints that different metabolic consequences of sleep apnea may operate on different timescales and through partially independent pathways. CPAP’s blood pressure benefit is real and well-documented, but it should not be expected to fix every metabolic abnormality associated with sleep apnea in every patient. Weight management, exercise, and medication remain important parts of the picture for most people dealing with both sleep apnea and hypertension.